June 5, 2024 - $3D Systems (DDD.US)$ shares surged 13.29% to $3.92 in pre-market trading on Wednesday. The company accounced largest contract award in company history, with estimated value approaching a quarter billion dollars over five years, to support indirect manufacturing process for clear aligners.

Yesterday, 3D Systems announced its expanded focus and technology roadmap tailored to deliver the largest range of solutions for a growing digital dentistry market. The portfolio will include solutions for alignment, protection, repair, and replacement of teeth – the broadest portfolio available from any additive manufacturing solutions provider.

The Company also announced the signing of a multi-year purchase agreement, with a value estimated to approach a quarter-billion dollars through 2028, in support of the indirect manufacturing process for clear aligners. The contract builds upon the exceptional legacy the Company has established as a key supplier of 3D printing technology to the clear aligner industry. 3D Systems’ technology today enables the manufacture of roughly one million patient-specific clear aligners per day across this rapidly growing market. The Company believes this milestone orthodontics contract provides a strong foundation upon which to launch the next phase of significant expansion in the dental market, which will include novel technology for the direct printing of clear aligner products.

Earlier this year, 3D Systems showcased the newest application of its additive manufacturing dental technologies with the introduction of a first-to-market solution for multi-material, jetted, one-piece dentures. The Company believes its unique denture solution delivers a durable, long-wear, aesthetically beautiful prosthetic to the patient, enabled by the formulation of bespoke materials for both teeth and gums. The solution has already garnered interest from leading dental labs, including Glidewell, the world’s largest producer of restorative dental devices. 3D Systems anticipates FDA clearance of the solution in the second half of 2024, with rapid commercialization to follow.